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1730 Abstracts December 2013walked, and total time walked. Univariate and multivariate methods were
used to assess the correlation between ambulation and type D personality.
Results: Seventy-one patients were enrolled with a mean age of
62.5 6 1.14 years and mean ABI of 0.55 6 0.03. Mean distance to symp-
toms, and total distance walked were 83.76 80.1 m, and 206.56 126.3 m,
respectively. There were no signiﬁcant correlations between the type D
group and the questionnaires assessing psychosocial factors and perception
of disease severity. At 6MWT, 83.1% of the patients developed symptoms,
and 57.4% quit because of symptoms. Type D personality was present in
29.6% of the population (study, n ¼ 21). Compared with the nontype D
population (control, n ¼ 50), there were no differences in demographic
factors, comorbidities, or baseline ABI. Univariate analysis of objective
measures of ambulation (Table) demonstrate statistically signiﬁcant lower
distance to symptoms in the study group, and trends toward lower total
distance walked and quitting the 6MWT. A logistic regression model for
patients who quit the 6MWT found that the study group had increased
odds of quitting (OR 7.71; P ¼ 0.009) when controlling for confounders. A
multiple linear regression model for total distance walked showed that the
study group walked an average of 33.2 6 13.3 meters less than the control
group (P ¼ .016) when controlling for confounding variables.
Conclusions: Despite equivalent demographics, comorbidities, base-
line ABI, and perception of disease severity, the study group was limited
in ambulation distance and more likely to quit the 6MWT. These data
suggest that personality type is a strong predictor of disease impact in
patients with IC. Further study is needed regarding progression of disease
and response to treatment based on type D personality.
Table. Univariate analysis of objective ambulation outcomes
Study Control
VariableF(type D, n ¼ 21)ig 1.(n ¼ 50) PAge, years 60.9 6 2.0 63.1 6 1.4 .36
ABI 0.55 6 0.26 0.55 6 0.19 .93
6MWT quit 70.0% 52.1% .17
6MWT developed symptoms 76.2% 86.0% .33
6MWT distance to symptoms, m 57.4 6 12.3 93.4 6 13.3 .05
6MWT total distance, m 170.3 6 25.0 221.6 6 18.8 .11Optimizing Treatment for Chronic Mesenteric Ischemia: A
Comparison of Open and Endovascular Repair in a Clinical Decision
Model
Wouter Hogendoorn1, M. G. Myriam Hunink2, Felix JV. Schlosser1, Frans
L. Moll3, Bart E. Muhs1, Bauer E. Sumpio1. 1Yale University, New Haven,
Conn; 2Erasmus MC, Rotterdam, The Netherlands; 3University Medical
Center Utrecht, Utrecht, The Netherlands
Objectives: Chronic mesenteric ischemia (CMI) is an uncommon
disease caused by stenosis or occlusion of one or more visceral arteries.
Open repair (OR) has been the treatment of choice for many years, but
endovascular repair (EV) has been increasingly utilized with good short-
term results. Unfortunately, there is no level-1-evidence that compares these
two major treatment modalities for the treatment of CMI, and there are no
clear guidelines on management strategies. In this study, we utilized a deci-
sion analysis model to evaluate the different interventions.Methods: A Markov-state transition model was developed using
TreeAge Pro 2012 (TreeAge Inc, Williamstown, Mass) to simulate a hypo-
thetical cohort of 10,000 65-year-old female patients with CMI requiring
treatment with either OR or EV. Data and probabilities to populate the
decision model, including perioperative mortality risks, complication-, rein-
tervention-, and patency rates and disease-speciﬁc mortality, were retrieved
from original and systematic reviews for CMI. Costs were retrieved using
the 2013 Medicare database. Outcomes evaluated were quality-adjusted
life years (QALYs), total expected lifetime costs and an incremental cost-
effectiveness ratio (ICER) evaluated from the healthcare perspective. Exten-
sive sensitivity analyses were performed for different clinical scenarios and
probabilistic sensitivity analysis was performed to assess robustness of the
model.
Results: For 65-year-old female patients with CMI and an average
risk for operation, EV is slightly preferred with 10.24 expected QALYs
(95% conﬁdence interval [CI], 9.98-10.40) vs 9.93 QALYs (95% CI,
9.64-10.19) for OR. The difference between the two strategies is compa-
rable to 4 months in perfect health (0.31 QALYs; 95% CI, 0.06-0.56).
Sensitivity analysis shows that the younger the patient, the greater the differ-
ence in effectiveness in favor of EV: 0.4 QALYs (at 50 years) to 0.1 QALYs
(at 95 years). Total expected reinterventions/patient are 1.56 for EV vs
0.28/patient in the OR group. At every age group, the number of expected
reinterventions is around ﬁve times higher for patients initially treated with
EV. Total expected costs for the reference-case patient are $48,440 6
$8,665 for OR and $43,099 6 $5,998 for EV. For patients between 50
years and 55 years old, EV is more expensive compared with OR but the
incremental cost-effectiveness ratio for EV is under the willingness-to-pay
threshold of $60,000/QALY. After the age of 55, costs for OR are higher
and effectiveness is lower, and therefore OR is dominated by EV.
Conclusions: The results of this decision analysis suggest that EV is
slightly favored for patients with CMI. Effectiveness of EV compared with
OR is always higher for every age group and risk proﬁle. Although EV
has up to ﬁve times more expected reinterventions, EV appears to be
cost-effective for all patient groups. Decision analysis provides a useful
means to monitor outcomes and cost-effectiveness of different treatment
options.
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Objectives: Carotid artery stenting (CAS) can offer advantages over
carotid endarterectomy (CEA) in certain patient populations, such as those
with hostile necks. However, CEA and CAS are fundamentally different.
CAS routinely covers the external carotid artery (ECA), and we hypothesize
that this increases the risk of ECA occlusion. Since the ECA can be an
important source of cerebral blood ﬂow in cases of high-grade internal
carotid artery stenosis or occlusion, ECA occlusion may be important to
long-term cerebral perfusion. Furthermore, CAS causes disturbed ﬂow
into the ECA that likely promotes ECA stenosis and may contribute to
in-stent restenosis (ISR). Our objective was to identify whether CAS
increased the rate of external carotid artery occlusion, and whether ECA
occlusion was associated with in-stent restenosis.
Methods: Patients undergoing CAS or CEA from February 200 to
February 2012 with follow-up carotid ultrasounds in our system were
